Projects per year
Personal profile
Education
- 2018 PhD, Graduate Institute of Clinical Medicine, College of Medicine, National Yang-Ming University
- 2003 MD, College of Medicine, National Defense Medical Center
Experience
- Director, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Director, Division of Gynecology, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Attending, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
- Associate Professor, Department of Obstetrics & Gynecology, School of Medicine, College of Medicine, Taipei Medical University
- Attending, Department of Obstetrics & Gynecology,Taipei Veterans General Hospital
Fingerprint
Dive into the research topics where Kuo-Chang Wen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
利用卵巢癌幹細胞分化模型建立漿液性卵巢上皮癌表基因分類系統
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
人類子宮內膜癌淋巴結轉移的分子預測
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
Article Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis
Chen, L. Y., Huang, R. L., Su, P. H., Lai, H. C., Wen, K. C., Chu, L. H., Weng, Y. C. & Wang, H. C., May 1 2022, In: International journal of molecular sciences. 23, 9, 5120.Research output: Contribution to journal › Article › peer-review
Open Access -
Prenatal case of RIT1 mutation associated Noonan syndrome by whole exome sequencing (WES) and review of the literature
Qiu, Z., Chang, W. T., Chou, Y. C., Wen, K. C., Ziying, Y., Yuen, K., Cai, X., Chang, T. Y., Lai, H. C. & Sung, P. L., 2022, (Accepted/In press) In: Taiwanese Journal of Obstetrics and Gynecology.Research output: Contribution to journal › Article › peer-review
-
Cytokine and epigenetic regulation of programmed death-ligand 1 in stem cell differentiation and cancer cell plasticity
Kuo, M. H., Chen, P. Y., Yang, Y. P., Zheng, M. Y., Miao, C. C., Wen, K. C., Chang, K. M., Chou, S. J., Wang, M. L., Chiou, S. H. & Chou, Y. T., Oct 2021, In: Stem Cells. 39, 10, p. 1298-1309 12 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
The prognostic nomogram in platinum-resistant ovarian cancer: How to develop and validate?
Wen, K. C., Sung, P. L. & Lai, H. C., Jun 2021, In: Chinese Clinical Oncology. 10, 3, 31.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y. C., Wen, K. C., Sung, P. L., Chou, Y. T., Liew, P. L., Chen, L. Y., Huang, R. L., Lai, H. C. & Chang, L. T., Dec 2020, In: Journal of Ovarian Research. 13, 1, 143.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus)
Datasets
-
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. (Contributor), Sung, P. (Contributor), Wu, A. T. (Contributor), Chou, P. (Contributor), Lin, J. (Contributor), Huang, C. F. (Contributor), Yeung, S. J. (Contributor) & Lee, M. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Neoadjuvant_metformin_added_to_conventional_chemotherapy_synergizes_anti-proliferative_effects_in_ovarian_cancer/12845522/1
Dataset
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. (Contributor), Sung, P. (Contributor), Wu, A. T. (Contributor), Chou, P. (Contributor), Lin, J. (Contributor), Huang, C. F. (Contributor), Yeung, S. J. (Contributor) & Lee, M. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://springernature.figshare.com/collections/Neoadjuvant_metformin_added_to_conventional_chemotherapy_synergizes_anti-proliferative_effects_in_ovarian_cancer/5099513/1
Dataset
-
Additional file 2 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. (Contributor), Sung, P. (Contributor), Wu, A. T. (Contributor), Chou, P. (Contributor), Lin, J. (Contributor), Huang, C. F. (Contributor), Yeung, S. J. (Contributor) & Lee, M. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.12845525.v1, https://springernature.figshare.com/articles/figure/Additional_file_2_of_Neoadjuvant_metformin_added_to_conventional_chemotherapy_synergizes_anti-proliferative_effects_in_ovarian_cancer/12845525/1
Dataset
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Chang, L. (Contributor), Chen, L. (Contributor), Lai, H. (Contributor), Sung, P. (Contributor), Chou, Y. (Contributor), Liew, P. (Contributor), Lin, Y. (Contributor), Huang, R. (Contributor) & Wen, K. (Contributor), figshare Academic Research System, Jan 1 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://doi.org/10.6084%2Fm9.figshare.13352142.v1
Dataset
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Wen, K. (Contributor), Chen, L. (Contributor), Chou, Y. (Contributor), Chang, L. (Contributor), Huang, R. (Contributor), Lin, Y. (Contributor), Lai, H. (Contributor), Sung, P. (Contributor) & Liew, P. (Contributor), figshare Academic Research System, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://doi.org/10.6084%2Fm9.figshare.c.5234313.v1
Dataset